Ceftazidime/avibactam susceptibility by three different susceptibility testing methods in carbapenemase-producing Gram-negative bacteria from Australia
Norelle L Sherry, Sarah L Baines, Benjamin P Howden
International Journal of Antimicrobial Agents | ELSEVIER SCIENCE BV | Published : 2018
Awarded by National Health and Medical Research Council Practitioner Fellowship
This work was funded by AstraZeneca, which provided the avibactam, Etests and antibiotic disks for testing. AstraZeneca's rights to ceftazidime/avibactam were acquired by Pfizer in December 2016. The funders had no role in study design, data collection or interpretation. NLS and SLB are supported by Australian Government Research Training Program Scholarships. BPH is supported by a National Health and Medical Research Council Practitioner Fellowship [GNT1105905].